Literature DB >> 17346854

The metabolic role of isoleucine in detoxification of ammonia in cultured mouse neurons and astrocytes.

Maja L Johansen1, Lasse K Bak, Arne Schousboe, Peter Iversen, Michael Sørensen, Susanne Keiding, Hendrik Vilstrup, Albert Gjedde, Peter Ott, Helle S Waagepetersen.   

Abstract

Cerebral hyperammonemia is a hallmark of hepatic encephalopathy, a debilitating condition arising secondary to liver disease. Pyruvate oxidation including tricarboxylic acid (TCA) cycle metabolism has been suggested to be inhibited by hyperammonemia at the pyruvate and alpha-ketoglutarate dehydrogenase steps. Catabolism of the branched-chain amino acid isoleucine provides both acetyl-CoA and succinyl-CoA, thus by-passing both the pyruvate dehydrogenase and the alpha-ketoglutarate dehydrogenase steps. Potentially, this will enable the TCA cycle to work in the face of ammonium-induced inhibition. In addition, this will provide the alpha-ketoglutarate carbon skeleton for glutamate and glutamine synthesis by glutamate dehydrogenase and glutamine synthetase (astrocytes only), respectively, both reactions fixing ammonium. Cultured cerebellar neurons (primarily glutamatergic) or astrocytes were incubated in the presence of either [U-13C]glucose (2.5 mM) and isoleucine (1 mM) or [U-13C]isoleucine and glucose. Cell cultures were treated with an acute ammonium chloride load of 2 (astrocytes) or 5 mM (neurons and astrocytes) and incorporation of 13C-label into glutamate, aspartate, glutamine and alanine was determined employing mass spectrometry. Labeling from [U-13C]glucose in glutamate and aspartate increased as a result of ammonium-treatment in both neurons and astrocytes, suggesting that the TCA cycle was not inhibited. Labeling in alanine increased in neurons but not in astrocytes, indicating elevated glycolysis in neurons. For both neurons and astrocytes, labeling from [U-13C]isoleucine entered glutamate and aspartate albeit to a lower extent than from [U-13C]glucose. Labeling in glutamate and aspartate from [U-13C]isoleucine was decreased by ammonium treatment in neurons but not in astrocytes, the former probably reflecting increased metabolism of unlabeled glucose. In astrocytes, ammonia treatment resulted in glutamine production and release to the medium, partially supported by catabolism of [U-13C]isoleucine. In conclusion, i) neuronal and astrocytic TCA cycle metabolism was not inhibited by ammonium and ii) isoleucine may provide the carbon skeleton for synthesis of glutamate/glutamine in the detoxification of ammonium.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346854     DOI: 10.1016/j.neuint.2007.01.009

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  22 in total

1.  Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction.

Authors:  Doaa A Ghareeb; Hani S Hafez; Hend M Hussien; Nihal F Kabapy
Journal:  Metab Brain Dis       Date:  2011-09-01       Impact factor: 3.584

2.  Detoxification of ammonia in mouse cortical GABAergic cell cultures increases neuronal oxidative metabolism and reveals an emerging role for release of glucose-derived alanine.

Authors:  Renata Leke; Lasse K Bak; Malene Anker; Torun M Melø; Michael Sørensen; Susanne Keiding; Hendrik Vilstrup; Peter Ott; Luis V Portela; Ursula Sonnewald; Arne Schousboe; Helle S Waagepetersen
Journal:  Neurotox Res       Date:  2010-05-18       Impact factor: 3.911

Review 3.  Effects of hyperammonemia on brain energy metabolism: controversial findings in vivo and in vitro.

Authors:  Arne Schousboe; Helle S Waagepetersen; Renata Leke; Lasse K Bak
Journal:  Metab Brain Dis       Date:  2014-03-01       Impact factor: 3.584

4.  Limited energy supply in Müller cells alters glutamate uptake.

Authors:  Anne Katrine Toft-Kehler; Dorte Marie Skytt; Kristian Arild Poulsen; Charlotte Taul Brændstrup; Georgi Gegelashvili; Helle Waagepetersen; Miriam Kolko
Journal:  Neurochem Res       Date:  2014-04-04       Impact factor: 3.996

5.  Human (13)N-ammonia PET studies: the importance of measuring (13)N-ammonia metabolites in blood.

Authors:  Susanne Keiding; Michael Sørensen; Ole Lajord Munk; Dirk Bender
Journal:  Metab Brain Dis       Date:  2010-03-09       Impact factor: 3.584

6.  Expression of Glutamate Decarboxylase (GAD) mRNA in the brain of bile duct ligated rats serving as a model of hepatic encephalopathy.

Authors:  Renata Leke; Themis R Silveira; Thayssa D C Escobar; Arne Schousboe
Journal:  Neurochem Res       Date:  2013-08-01       Impact factor: 3.996

Review 7.  Cerebral effects of ammonia in liver disease: current hypotheses.

Authors:  Peter Ott; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2014-02-04       Impact factor: 3.584

Review 8.  The brain in acute liver failure. A tortuous path from hyperammonemia to cerebral edema.

Authors:  Peter Nissen Bjerring; Martin Eefsen; Bent Adel Hansen; Fin Stolze Larsen
Journal:  Metab Brain Dis       Date:  2008-12-03       Impact factor: 3.584

9.  Glial metabolism of isoleucine.

Authors:  Radovan Murín; Ghasem Mohammadi; Dieter Leibfritz; Bernd Hamprecht
Journal:  Neurochem Res       Date:  2008-09-12       Impact factor: 3.996

Review 10.  Role of branched chain amino acids in cerebral ammonia homeostasis related to hepatic encephalopathy.

Authors:  Lasse K Bak; Helle S Waagepetersen; Michael Sørensen; Peter Ott; Hendrik Vilstrup; Susanne Keiding; Arne Schousboe
Journal:  Metab Brain Dis       Date:  2013-01-31       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.